Vernal Keratoconjunctivitis
📧 Sign up to get email alerts when something new happens for Vernal Keratoconjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis [Phase 2]
Phase 2 randomized trial comparing the novel agent T1695 with ciclosporin for moderate to severe vernal keratoconjunctivitis; recruitment is…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Topical rVA576 for Treatment of Atopic Keratoconjunctivitis [Phase 1, Phase 2]
A Phase 1/2 study of topical rVA576 for atopic keratoconjunctivitis, vernal keratoconjunctivitis, and allergic conjunctivitis was terminated…
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis [Phase 3]
Phase 3 double-masked trial of NOVA22007 (cyclosporine) vs vehicle in pediatric active severe Vernal Keratoconjunctivitis completed, with re…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) [Phase 2, Phase 3]
Clinical trial update comparing Nova22007 to vehicle in vernal keratoconjunctivitis (phase 2/3) with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
This clinical trial update discusses using topical tacrolimus ointment applied to the eyelids to treat refractory Vernal Keratoconjunctiviti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis [Phase 4]
A Phase 4 clinical trial evaluating a novel combined therapy for refractory Vernal Keratoconjunctivitis has completed. The study was conduct…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Topical Tacrolimus in Vernal Keratoconjunctivitis [Phase 4]
An update on a Phase 4 trial evaluating topical tacrolimus for Vernal keratoconjunctivitis, with the study status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [Phase 3]
Phase III trial evaluating 0.1% tacrolimus ophthalmic suspension for Vernal keratoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda [Phase 4]
This update reports that a Phase 4 trial evaluating topical cyclosporine for Vernal keratoconjunctivitis in Rwanda has been completed.
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment [Phase 2, Phase 3]
The clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating the efficacy of oral Lactobacillus rhamnosus GG for…
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis [Phase 3]
A Phase 3 study evaluating cyclosporin A eye drops for Vernal keratoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [Phase 3]
Phase III long-term, open-label extension study of 0.1% tacrolimus ophthalmic suspension in vernal keratoconjunctivitis completed.
-
CLINICAL_TRIALS trial_result · 2006-07-27Clinical Trial Update: Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis [Phase 4]
Phase 4 study evaluating the clinical and biological efficacy of NAAXIA SINE in vernal keratoconjunctivitis has completed.